Open AccessLatamoxef-induced severe thrombocytopenia during the treatment of pulmonary infection: A case report
Author(s) -
Ruo-Ying Zhang,
Junjie Zhang,
Jinmeng Li,
Yingying Xu,
Yue-Huan Xu,
Xiaoxiao Cai
Publication year - 2022
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v10.i22.7906
Subject(s) - medicine , latamoxef , ecchymosis , platelet , gastroenterology , tuberculosis , bacteroides fragilis , surgery , antibiotics , cephalosporin , pathology , microbiology and biotechnology , biology
Latamoxef shows excellent antibacterial activity against anaerobic bacteria such as Bacteroides fragilis . Reports of thrombocytopenic toxicity of latamoxef are limited. This report presents a case of severe thrombocytopenia possibly induced by latamoxef, an infrequent adverse drug reaction in a young patient with tuberculosis and Crohn's disease in China.